Effects of buprenorphine on a cecal ligation and puncture model in C57BL/6 mice

Journal of the American Association for Laboratory Animal Science

Volumn 51, Issue 3, 2012, Pages 357-365

  Cotroneo, Tara M ^a   Hugunin, Kelly M S ^c   Shuster, Katherine A ^a   Hwang, Hae J ^a   Kakaraparthi, Bala N ^a   Nemzek Hamlin, Jean A ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CECAL LIGATION AND PUNCTURE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MEGADOSE; FEMALE; LEUKOCYTE COUNT; LIGATION; LOW DRUG DOSE; MALE; MORTALITY; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PERITONEUM LAVAGE; POLYMICROBIAL SEPSIS; SEPSIS; SURVIVAL;

ANALGESICS, OPIOID; ANIMAL WELFARE; ANIMALS; BLOOD CHEMICAL ANALYSIS; BUPRENORPHINE; CECUM; CELL COUNT; COINFECTION; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LIGATION; MALE; MICE; MICE, INBRED C57BL; PERITONEAL LAVAGE; PUNCTURES; SEPSIS;

EID: 84862568339     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Adamson TW, Kendall L, Goss S, Grayson K, Touma C, Palme R, Chen J, Borowsky A. 2010. Assessment of carprofen and buprenorphine on recovery of mice after surgical removal of the mammary fat pad. J Am Assoc Lab Anim Sci 49:610-616.
2. Bartok RE, Craft RM. 1997. Sex differences in opioid antinociception. J Pharmacol Exp Ther 282:769-778. (Pubitemid 27340177)
3. Beishuizen A, Thijs LG. 2003. Endotoxin and the hypothalamo-pituitary- adrenal (HPA) axis. J Endotoxin Res 9:3-24. (Pubitemid 36322480)
4. Buras JA, Holzmann B, Sitkovsky M. 2005. Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4:854-865. (Pubitemid 41553966)
5. Carrigan KA, Saurer TB, Ijames SG, Lysle DT. 2004. Buprenorphine produces naltrexone reversible alterations of immune status. Int Immunopharmacol 4:419-428. (Pubitemid 38375974)
6. Dahan A, Kest B, Waxman AR, Sarton E. 2008. Sex-specific responses to opiates: animal and human studies. Anesth Analg 107:83-95.
7. Deitch EA. 2005. Rodent models of intra-abdominal infection. Shock 24:19-23.
8. Dejager L, Pinheiro I, Dejonckheere E, Libert C. 2011. Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends Microbiol 19:198-208.
9. Foltz CJ, Ullman-Cullere M. 1999. Guidelines for assessing the health and condition of mice. Lab Anim 28:28-32. (Pubitemid 129631140)
10. Gades NM, Danneman PJ, Wixson SK, Tolley EA. 2000. The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. Contemp Top Lab Anim Sci 39:8-13.
11. Gomez-Flores R, Weber RJ. 2000. Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology 48:145-156. (Pubitemid 30608671)
12. Hadid R, Spinedi E, Chautard T, Giacomini M, Gaillard RC. 1999. Role of several mediators of inflammation on the mouse hypothalamo-pituitary-adrenal axis response during acute endotoxemia. Neuroimmunomodulation 6:336-343. (Pubitemid 29418462)
13. Hawk CT, Leary SL, Morris TH; American College of Laboratory Animal Medicine; European College of Laboratory Animal Medicine. 2005. Formulary for laboratory animals. Ames (IA): Blackwell Publishing.
14. Hilburger ME, Adler MW, Truant AL, Meissler JJ, Satishchandran V, Rogers TJ, Eisenstein TK. 1997. Morphine induces sepsis in mice. J Infect Dis 176:183-188. (Pubitemid 27272867)
15. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW, Bland KI, Chaudry IH. 2005. Cecal ligation and puncture. Shock 24:52-57.
16. Hugunin KMS, Fry C, Shuster K, Nemzek J. 2010. Effects of tramadol and buprenorphine on select immunologic factors in a cecal ligation and puncture model. Shock 34:250-260.
17. Jenkins WL. 1987. Pharmacologic aspects of analgesic drugs in animals: an overview. J Am Vet Med Assoc 191:1231-1240. (Pubitemid 17156300)
18. Kahlke V, Dohm C, Mees T, Brotzmann K, Schreiber S, Schroder J. 2002. Early interleukin-10 treatment improves survival and enhances immune function only in males after hemorrhage and subsequent sepsis. Shock 18:24-28.
19. Klein SL. 2000. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev 24:627-638. (Pubitemid 30625129)
20. Leon LR. 1998. Role of IL6 and TNF in thermoregulation and survival during sepsis in mice. Am J Physiol 275:R269-R277.
21. Marriott I, Huet-Hudson YM. 2006. Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res 34:177-192. (Pubitemid 44195935)
22. Martin GS, Mannino DM, Eaton S, Moss M. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554. (Pubitemid 36437931)
23. Martucci C, Panerai AE, Sacerdote P. 2004. Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses. Pain 110:385-392. (Pubitemid 38953304)
24. Morton DB, Griffiths PH. 1985. Guidelines on the recognition of pain, distress, and discomfort in experimental animals and an hypothesis for assessment. Vet Rec 116:431-436.
25. Nachtigall I. 2011. Gender-related outcome difference is related to course of sepsis on mixed ICUs: a prospective, observational clinical study. Crit Care 15:R151.
26. Nemzek JA, Hugunin KM, Opp MR. 2008. Modeling sepsis in the laboratory: merging sound science with animal well-being. Comp Med 58:120-128.
27. Nemzek JA, Siddiqui J, Remick DG. 2001. Development and optimization of cytokine ELISAs using commercial antibody pairs. J Immunol Methods 255:149-157. (Pubitemid 32695391)
28. Nemzek JA, Xiao HY, Minard A, Bolgos G, Remick D. 2004. Humane endpoints in shock research. Shock 21:17-25.
29. Odunayo A, Dodam JR, Kerl ME, DeClue AE. 2010. Immunomodulatory effects of opioids. J Vet Emerg Crit Care (San Antonio) 20:376-385.
30. Office of Laboratory Animal Welfare. 2002. Public Health Service policy on humane care and use of laboratory animals. Bethesda (MD): Department of Health and Human Services.
31. Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA. 2002. Six at six: Interleukin-6 measured 6 H after the initiation of sepsis predicts mortality over 3 days. Shock 17:463-467.
32. Sacerdote P. 2006. Opioids and the immune system. Palliat Med 20:S9-S15. (Pubitemid 43871329)
33. Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F. 1998. Gender differences in human sepsis. Arch Surg 133:1200-1205. (Pubitemid 28516271)
34. Tubbs JT, Kissling G, Travlos G, Goulding D, Clark J, King Herbert A, Blankenship Paris T. 2011. Effects of buprenorphine, meloxicam, and flunixin meglumine as postoperative analgesia in mice. J Am Assoc Lab Anim Sci 50:185-191.
35. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW. 2000. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 26:167-172. (Pubitemid 30186590)
36. Yu S, Zhang X, Sun Y, Peng Y, Johnson J, Mandrell T, Shukla AJ, Laizure SC. 2006. Pharmacokinetics of buprenorphine after intravenous administration in the mouse. J Am Assoc Lab Anim Sci 45:12-16. (Pubitemid 43828863)
37. Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, Chaudry IH. 1997. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 25:106-110. (Pubitemid 27015048)